Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation

Affiliations

• ¹ Antimicrobial Resistance Centre, Norwegian Institute of Public Health, Oslo 0213, Norway. Electronic address: chaa@fhi.no.
• ² Department of Engineering Sciences, Industrial Engineering and Management, Uppsala University, Uppsala, Sweden.
• ³ Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
• ⁴ European Public Health Alliance, Brussels, Belgium.
• ⁵ Department of Business Studies, Uppsala University, Uppsala, Sweden.
• ⁶ Department of Infectious Diseases, University Hospital Virgen del Rocio, IBiS, CIBERINFEC, Seville, Spain.
• ⁷ Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
• ⁸ Hôpitaux Universitaires de Genève, Geneva, Switzerland.
• ⁹ Laboratoire National de Santé, Dudelange, Luxembourg.
• ¹⁰ University of Limoges, INSERM, CHU Limoges, RESINFIT, Limoges, France.
• ¹¹ AIFA-Italian Medicines Agency, Rome, Italy.
• ¹² Center for Global Development, London, UK.
• ¹³ Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
• ¹⁴ Graduate Institute of International and Development Studies, Geneva, Switzerland.
• ¹⁵ London School of Economics and Political Science, London, UK.
• ¹⁶ Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/University Hospital Virgen del Rocio, Seville, Spain.
• ¹⁷ Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Ljubljana, Slovenia.
• ¹⁸ Norwegian Ministry of Foreign Affairs, Oslo, Norway.
• ¹⁹ Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
• ²⁰ University of Verona, Verona, Italy.
• ²¹ Center for Anti-Infective Agents, Vienna, Austria.
• ²² Austrian National Public Health Institute, Vienna, Austria; Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
• ²³ Statens Serum Institut, Copenhagen, Denmark.
• ²⁴ ReAct Europe, Uppsala University, Uppsala, Sweden.
• ²⁵ The Review on Antimicrobial Resistance, London, UK.